mifepristone has been researched along with mobic in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Adamson, L; Bocking, AD; Challis, JR; Fraser, M; Lye, SJ; McKeown, KJ; Riggs, KW; Rurak, D; Small, C | 1 |
Adamson, SL; Challis, JR; Lye, SJ; Rac, VE; Rurak, D; Scott, CA; Small, C | 1 |
Najera, DB | 1 |
2 review(s) available for mifepristone and mobic
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Emergency contraception: Focus on the facts.
Topics: Contraception; Contraception, Postcoital; Contraceptives, Oral, Hormonal; Cyclooxygenase Inhibitors; Female; Health Services Accessibility; Humans; Intrauterine Devices; Levonorgestrel; Meloxicam; Mifepristone; Norpregnadienes; Ovulation Inhibition; Pregnancy; Thiazines; Thiazoles | 2016 |
5 other study(ies) available for mifepristone and mobic
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Altered fetal pituitary-adrenal function in the ovine fetus treated with RU486 and meloxicam, an inhibitor of prostaglandin synthase-II.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenocorticotropic Hormone; Animals; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Female; Hydrocortisone; In Vitro Techniques; Isoenzymes; Labor, Induced; Meloxicam; Mifepristone; Pituitary-Adrenal System; Pregnancy; Prostaglandin-Endoperoxide Synthases; Sheep; Thiazines; Thiazoles; Tocolytic Agents; Uterine Contraction | 2000 |
Meloxicam effectively inhibits preterm labor uterine contractions in a chronically catheterized pregnant sheep model: impact on fetal blood flow and fetal-maternal physiologic parameters.
Topics: Abortifacient Agents, Steroidal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Electromyography; Female; Fetus; Intestines; Kidney; Labor, Induced; Meloxicam; Mifepristone; Models, Animal; Obstetric Labor, Premature; Osmolar Concentration; Pregnancy; Random Allocation; Regional Blood Flow; Sheep; Thiazines; Thiazoles; Tocolytic Agents; Urine; Uterine Contraction | 2006 |